Cargando…
In Clinic Optometrist Insertion of Dextenza (Dexamethasone Ophthalmic Insert 0.4mg) Prior to Cataract Surgery: The PREPARE Study
PURPOSE: To evaluate the clinical outcomes with optometrist pre-surgical insertion of dexamethasone ophthalmic insert 0.4mg in the clinical office setting in patients undergoing same-day cataract surgery compared to standard of care steroid therapy. METHODS: In this prospective, contralateral eye tr...
Autores principales: | Ibach, Mitchel J, Zimprich, Larae, Wallin, Doug D, Olevson, Collin, Puls-Boever, Keeley, Thompson, Vance |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384970/ https://www.ncbi.nlm.nih.gov/pubmed/35992569 http://dx.doi.org/10.2147/OPTH.S374405 |
Ejemplares similares
-
Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (Dextenza™): results of a qualitative survey
por: Gira, Joseph P, et al.
Publicado: (2017) -
Defocus Curve of Emerging Presbyopic Patients
por: Shafer, Brian M, et al.
Publicado: (2023) -
Dexamethasone 0.4mg Sustained-Release Intracanalicular Insert in the Management of Ocular Inflammation and Pain Following Ophthalmic Surgery: Design, Development and Place in Therapy
por: Brooks, Cassandra C, et al.
Publicado: (2020) -
A Randomized Fellow-Eye Clinical Trial to Evaluate Patient Preference for Dexamethasone Intracanalicular Insert or Topical Prednisolone Acetate for Control of Postoperative Symptoms Following Bilateral Femtosecond Laser in Site Keratomileusis (LASIK)
por: Greenwood, Michael D, et al.
Publicado: (2020) -
Prospective, Randomized, Fellow Eye-Controlled Study of Postoperative Pain and Inflammation Control with an Intracanalicular Dexamethasone 0.4 mg Ophthalmic Insert Following Small Incision Lenticule Extraction
por: Jee, Kathleen J, et al.
Publicado: (2022)